Description: The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.
Exchange: F
Country: DE
Currency: Euro (€)
Category: Sector Equity Biotechnology
| Asset Allocation | |||
|---|---|---|---|
| Asset Class | Long % | Short % | Net Assets |
| Stock US | 87.95 | 0.00 | 87.95 |
| Stock non-US | 12.03 | 0.00 | 12.03 |
| Cash | 0.03 | 0.00 | 0.02 |
| Sector Weights | ||
|---|---|---|
| Sector | Equity % | Relative to Category |
| Healthcare | 100.00 | 99.95 |
| World Regions | ||
|---|---|---|
| Region | Equity % | Relative to Category |
| North America | 88.69 | 86.85 |
| United Kingdom | 5.26 | 2.20 |
| Europe Developed | 3.93 | 7.33 |
| Asia Emerging | 2.01 | 2.50 |
| Asia Developed | 0.11 | 0.32 |
| Japan | 0.00 | 0.63 |
| Australasia | 0.00 | 0.14 |
| Africa/Middle East | 0.00 | 0.02 |